About
Drug discovery & development
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
559
By Phase
PHASE1/PHASE2: 2PHASE2: 4PHASE1: 1
By Status
COMPLETED: 7
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04774328Lead Sponsor
Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
PHASE1/PHASE2Completed
34 participants
Started: Sep 9, 2020 · Completed: Jun 15, 2021
NCT04203537Lead Sponsor
Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)
PHASE1/PHASE2Completed
193 participants
Started: Dec 4, 2019 · Completed: Oct 26, 2020
NCT03885596Lead Sponsor
Open-Label CA-008 (Vocacapsaicin) in Bunionectomy
PHASE2Completed
36 participants
Started: Mar 25, 2019 · Completed: Oct 22, 2019
NCT03789318Lead Sponsor
Study in Subjects Undergoing Complete Abdominoplasty
PHASE2Completed
54 participants
Started: Dec 3, 2018 · Completed: Jun 12, 2019
NCT03731364Lead Sponsor
Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty
PHASE2Completed
55 participants
Started: Oct 29, 2018 · Completed: May 31, 2019
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...